For more stories like this, sign up for the PLANADVISERdash daily newsletter.
Turner Brings Out Three Long/Short Funds
The funds seek to capitalize on rising stocks in their long positions and on declining stocks in their short positions, the company reports. The three funds include:
- Turner Market Neutral Fund, managed by Matthew Glaser, contains a balance of long and short investments in different stocks across all major market sectors. The fund has Institutional Class shares (ticker symbol: TMNEX), Investor Class shares (ticker symbol: TMNFX), and Class C shares (ticker symbol: TMNCX). Glaser, chief of investment strategies and executive managing director, joined Turner in 2007. He previously worked for Susquehanna International Group.
- Turner Medical Sciences Long/Short Fund, managed by Vijay Shankaran, is a diversified fund of long and short investments in health-care companies of all market capitalizations. The fund offers Institutional Class shares (ticker symbol: TMSEX), Investor Class shares (ticker symbol: TMSFX), and Class C shares (ticker symbol: TMSCX). Shankaran, who is a medical doctor and holds a doctorate in immunology, is a senior portfolio manager/global security analyst. He came to Turner in 2006 from Caxton Associates.
- Turner Titan Fund, managed by Christopher Baggini, is a global, diversified fund of long and short investments in all major market sectors, with a focus on large cap-stocks. The fund offers Institutional Class shares (ticker symbol: TTLEX), Investor Class shares (ticker symbol: TTLFX), and Class C shares (ticker symbol: TTLCX). Baggini, senior portfolio manager/global security analyst has been with Turner since June of 2010.
The minimum initial investment is $100,000 for Institutional Class shares and $2,500 for Investor Class and Class C shares. For Individual Retirement Accounts, the minimum initial investment is $100,000 for Institutional Class shares and $2,000 for Investor Class and Class C shares.
You Might Also Like:

Retail Investing AUM Will Likely Slow in Next 5 Years, But Sales Will Rebound

US Retirement Assets Hit Record $40T
